[The strategy of cancer gene therapy].
Ito
Y
Y
Fourth Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan.
Niitsu
Y
Y
D016207:Cytokines / Q000235:genetics; D015774:Ganciclovir; D019450:Genes, MDR; D016147:Genes, Tumor Suppressor / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D016376:Oligonucleotides, Antisense; D009857:Oncogenes / Q000235:genetics; D011355:Prodrugs / Q000378:metabolism; D016372:RNA, Antisense; D016337:RNA, Catalytic; D013489:Suppression, Genetic; D013937:Thymidine Kinase / Q000235:genetics
D016207:Cytokines; D016376:Oligonucleotides, Antisense; D011355:Prodrugs; D016372:RNA, Antisense; D016337:RNA, Catalytic; D013937:Thymidine Kinase; D015774:Ganciclovir